Central Nervous System Infection Following Allogeneic Hematopoietic Stem Cell Transplantation
Conclusion Multivariate analysis revealed that high-risk disease status was a risk factor for developing CNS infection (p = .02), and that overall survival at 3 years after allo-HSCT was 33% in patients with CNS infection and 53% in those without CNS infection (p = .04).
Source: Hematology Oncology and Stem Cell Therapy - Category: Cancer & Oncology Source Type: research
More News: Adenoviruses | Cancer & Oncology | Cytomegalovirus | Enterococcus | Hematology | Stem Cell Therapy | Stem Cells | Transplants